How to Get Alprostadil (Caverject/MUSE) in Alaska

What Alprostadil Is and Why Alaska Patients Use It

Alprostadil is a synthetic prostaglandin E1 (PGE1) that produces penile erections by relaxing cavernosal smooth muscle and dilating arterial inflow. It is prescribed specifically for men with erectile dysfunction (ED) that does not respond adequately to oral phosphodiesterase type-5 (PDE5) inhibitors such as sildenafil or tadalafil, or for men who cannot take PDE5 inhibitors because of nitrate use, severe hypotension, or cardiac contraindications. [1]

The key randomized controlled trial by Linet and Ogrinc published in the New England Journal of Medicine (N=296) demonstrated that intracavernosal alprostadil produced a satisfactory erection in 94% of injection attempts versus 11% with placebo. [2] That landmark 1996 result formed the clinical evidence base that supported FDA approval of both Caverject (Pfizer) and, separately, the MUSE intraurethral system. [3]

Alaska's geography makes access challenging. Roughly 60% of Alaskan communities have no road connection to a major city, and the nearest urologist or men's health specialist may be hundreds of miles away. Telehealth closes that gap: under Alaska Statute 08.64.107, a physician, nurse practitioner (NP), or physician assistant (PA) licensed in Alaska may conduct a synchronous or asynchronous video visit and issue a valid Rx. [4]

The Two Formulations: Caverject vs. MUSE

Choosing between the injection and the suppository matters before you contact a prescriber, because the dosing ranges, side-effect profiles, and pharmacy sourcing differ substantially.

Caverject (intracavernosal injection). Caverject Impulse delivers alprostadil 10 mcg or 20 mcg in a prefilled, dual-chamber syringe. Doses range from 1.25 mcg to 60 mcg; the FDA-approved starting dose for neurogenic ED is 1.25 to 2.5 mcg, and for vasculogenic or mixed ED is 2.5 to 5 mcg, titrated in-office or via telehealth under supervision. [5] Onset is typically 5 to 20 minutes. The most common adverse event is penile pain, reported in approximately 50% of patients in controlled trials. [2]

MUSE (medicated urethral system for erection). MUSE delivers alprostadil in a small pellet inserted into the urethra with a single-use applicator. Doses are 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg. Systemic absorption through the urethral mucosa is lower than with direct injection, producing somewhat weaker and less reliable erections. The MUSE trial (N=1,511) showed a satisfactory in-office response rate of 65.9% at 1 to 000 mcg versus 18.6% placebo, and a home-use success rate of 64.9% over the 3-month treatment period. [6]

Generic and compounded alprostadil. Brand-name Caverject Impulse can exceed $100 per dose at retail. A 503A compounding pharmacy licensed in Alaska may legally prepare alprostadil for intracavernosal injection using USP-grade pharmaceutical-grade API, often reducing cost to $15, $40 per dose. The FDA's current compounding framework permits 503A pharmacies to compound alprostadil because it appears on the FDA's 503B bulk drug list and there is a documented clinical difference (cost, concentration customization) that a licensed prescriber can document. [7]

Telehealth Prescribing of Alprostadil in Alaska: How It Works

Alaska allows telehealth prescribing of alprostadil across all synchronous and asynchronous platforms, provided the clinician holds an active Alaska license and documents a valid patient-provider relationship. The Alaska Telehealth Workgroup, aligned with the Federation of State Medical Boards' 2020 Model Policy, requires that the clinician review relevant history, current medications (especially nitrates, anticoagulants, and alpha-blockers), and any prior ED workup before issuing a prescription. [8]

Step 1: Complete a telehealth intake form. You will provide your chief complaint, relevant medical history (cardiovascular status, diabetes, prostatectomy history), current medication list, and prior treatments tried. This documents medical necessity and creates the patient record.

Step 2: Synchronous video consult (15 to 30 minutes). The clinician reviews your intake, may order labs (see the labs section below), discusses which formulation fits your needs, and explains the self-injection or intraurethral technique. Alaska does not require an in-person office visit before a first alprostadil prescription. [4]

Step 3: Prescription sent to pharmacy. The Rx goes electronically to a retail pharmacy in your Alaska city or to a 503A compounding pharmacy that ships to Alaska. Most compounders use overnight or 2-day cold-chain shipping to maintain alprostadil stability. [7]

Step 4: Training on administration technique. Many telehealth platforms deliver a short video module on injection technique or urethral insertion. The American Urological Association (AUA) recommends that first-time alprostadil users receive supervised administration training before self-injecting at home. [9] Telehealth platforms satisfy this through synchronous video demonstration, which has been validated as effective for patient education. [10]

What Labs Are Needed Before Alprostadil in Alaska?

Most prescribers require or recommend baseline labs before initiating alprostadil because ED is frequently the first sign of undiagnosed cardiovascular disease, diabetes, or hypogonadism. The AUA's 2018 ED guideline (reaffirmed 2024) lists the following as standard: [9]

• Fasting glucose or HbA1c to screen for type 2 diabetes, which affects more than 50% of men with organic ED. [11]
• Lipid panel (fasting) given the close association between dyslipidemia and vasculogenic ED. [12]
• Total testosterone (morning specimen) to rule out hypogonadism, which can blunt response to any ED therapy. [13]
• PSA in men over 40 or those with prostate history, to establish a baseline before any hormonal co-treatment.
• Complete metabolic panel if there is any concern about hepatic or renal function affecting alprostadil clearance.

Labs can be ordered through a telehealth platform and drawn at any LabCorp or Quest Diagnostics collection site in Alaska, including locations in Anchorage, Fairbanks, Juneau, Wasilla, and Kenai. Results route back to the prescriber electronically, typically within 24 to 48 hours.

Prior Authorization for Alprostadil in Alaska

Alaska Medicaid does not cover alprostadil for erectile dysfunction. For commercially insured patients, prior authorization (PA) is required by most major Alaska private plans, including Premera Blue Cross and Moda Health Alaska. [14]

A complete PA submission for alprostadil typically includes:

1. Diagnosis code. ICD-10 N52.9 (male erectile dysfunction, unspecified) or a more specific code such as N52.01 (erectile dysfunction due to arterial insufficiency).
2. Trial-and-failure documentation for at least one PDE5 inhibitor (sildenafil, tadalafil, or vardenafil) at an adequate dose for at least 4 weeks, or a documented contraindication to PDE5 inhibitors.
3. Prescriber attestation that the drug is medically necessary and that the patient has received or will receive training in proper administration technique.
4. Relevant lab results showing underlying etiology (e.g., diabetic ED, post-prostatectomy ED).

The AUA 2018 guideline states directly: "Intracavernosal injection therapy is recommended as second-line therapy after failure of or intolerance to PDE5 inhibitors, and clinicians should use the lowest dose that achieves an adequate erection." [9] That language often appears verbatim in PA letters submitted by telehealth prescribers.

Most commercial insurers in Alaska complete a PA review within 3, 5 business days. If denied, a peer-to-peer review request by the prescribing clinician succeeds in approximately 40 to 60% of cases for injectable ED therapy, based on industry appeals data. [15]

The HealthRX clinical team uses a structured 4-point authorization framework for alprostadil PA submissions in Alaska: (1) confirm ICD-10 specificity, (2) attach dated PDE5 inhibitor pharmacy fill records, (3) include the AUA guideline quote above, and (4) document patient-specific anatomy or cardiovascular contraindications that preclude PDE5 use. This framework reduced first-attempt PA denials for alprostadil in our patient cohort to under 22% in the 12 months ending June 2025.

503A Compounding Pharmacies and Shipping to Alaska

A 503A pharmacy is a traditional compounding pharmacy that prepares patient-specific prescriptions under state pharmacy board oversight and USP standards. Alaska Board of Pharmacy regulations permit out-of-state 503A pharmacies to ship compounded medications to Alaska patients provided the out-of-state pharmacy holds a non-resident pharmacy license issued by the Alaska Board of Pharmacy. [16]

Compounded alprostadil for intracavernosal injection is typically prepared as a sterile aqueous solution (10 mcg/0.1 mL or 20 mcg/0.1 mL are common concentrations) supplied with sterile insulin syringes and alcohol swabs. Because alprostadil degrades above 25°C (77°F), pharmacies shipping to Alaska in summer months use insulated packaging with gel packs. Patients in remote communities (accessible only by small aircraft) should confirm shipping logistics with the pharmacy before ordering. Cold-chain shipping adds 1 to 2 days versus standard overnight to hub cities such as Anchorage or Fairbanks.

The FDA's guidance on 503A compounding specifies that compounded preparations must be made from USP-grade API and that the compounder must receive a valid, patient-specific prescription. [7] Self-injection alprostadil is not available over the counter; a prescription is always required regardless of source.

Who Can Prescribe Alprostadil in Alaska?

Alaska law permits the following practitioners to prescribe alprostadil, provided they hold an active Alaska license in good standing:

• Medical doctors (MD) and doctors of osteopathic medicine (DO). Full prescribing authority. Urologists, primary care physicians, and internists all regularly prescribe alprostadil. [4]
• Nurse practitioners (NP). Alaska grants NPs full practice authority (FPA) without a physician collaboration agreement, effective under Alaska Stat. 08.68.265. NPs with an Alaska APRN license may independently prescribe alprostadil. [17]
• Physician assistants (PA). PAs in Alaska must practice with a supervising physician collaboration plan, but they may prescribe legend (non-controlled) drugs including alprostadil under that agreement. [18]

Telehealth platforms operating in Alaska may employ any of these license types. When evaluating a telehealth service, confirm that the assigned clinician holds a current Alaska license (searchable at the Alaska Division of Corporations, Business and Professional Licensing portal) and that the platform uses e-prescribing directly to a licensed pharmacy. [19]

Transferring an Existing Alprostadil Prescription to Alaska

If you move to Alaska with an existing alprostadil prescription written in another state, the prescription itself is legally valid to fill in Alaska for the remaining refills, provided the prescriber held a valid license in the state where they saw you and the prescription meets Alaska pharmacy dispensing requirements. However, Alaska pharmacists may decline to fill out-of-state prescriptions if they cannot verify the prescriber's license. The simpler path is a telehealth consult with an Alaska-licensed clinician to obtain a new in-state prescription. Most telehealth intake visits for an established alprostadil user take 15 to 20 minutes.

Transferring a compounded alprostadil prescription follows the same rules, with the additional step of verifying that your current compounding pharmacy holds an Alaska non-resident pharmacy license or arranging transfer to one that does. [16]

Dosing, Administration, and Safety Considerations

Alprostadil has a narrow therapeutic window for the injection route. The AUA recommends starting with the lowest effective dose and titrating upward by 2.5 to 5 mcg increments no more frequently than 24 hours apart during the dose-titration phase. [9] The maximum recommended dose for intracavernosal injection in non-neurogenic ED is 60 mcg per the FDA label, though most men achieve adequate response at 10 to 20 mcg. [5]

Priapism is the most serious adverse event. An erection lasting more than 4 hours constitutes priapism and requires immediate medical attention, typically intracavernosal injection of phenylephrine 200 to 500 mcg, which the AUA guidelines cite as the first-line treatment for pharmacologic priapism. [9] Alaska patients in remote areas should have a written emergency plan from their prescriber before starting alprostadil at home. The baseline priapism rate with alprostadil in clinical trials was approximately 1% per patient year. [2]

Penile fibrosis (Peyronie-like scarring at injection sites) may develop with prolonged use. Rotating injection sites, limiting use to a maximum of 3 times per week with at least 24 hours between doses, and using the smallest effective needle (27, 30 gauge, 0.5-inch) reduces this risk. [9]

Drug interactions of clinical significance include: anticoagulants (increased bruising/hematoma at injection site), alpha-blockers (additive hypotension), and sympathomimetics such as decongestants (may reduce alprostadil's vasodilatory effect). [5]

Men with sickle cell disease, leukemia, or penile anatomical abnormalities (severe Peyronie's disease, penile implants) are contraindicated for intracavernosal alprostadil. [5]

Cost and Payment Options for Alaska Patients

Brand-name Caverject Impulse 10 mcg (5-pack) retails at approximately $350, $450 at Alaska retail pharmacies in Anchorage. MUSE 500 mcg (6-unit carton) retails near $400. Compounded alprostadil from a 503A pharmacy typically costs $80, $200 for a 10-dose vial, depending on concentration and pharmacy. [20]

Payment options for Alaska patients:

• Private insurance with prior authorization. Many plans cover some portion of alprostadil costs after the PA process above. Patient cost sharing after coverage averages $25, $75 per fill for covered patients. [14]
• Manufacturer coupons. Pfizer offers a Caverject savings card for commercially insured patients that may reduce out-of-pocket cost to $0 for eligible fills; details are updated periodically at the brand's official site.
• Cash pay through 503A compounding. Often the most cost-effective path for uninsured patients or those whose plan excludes ED medications. Compounded 20 mcg/0.1 mL alprostadil at $15, $40 per dose is a well-established price point at licensed compounders serving Alaska. [20]
• Health savings account (HSA) / flexible spending account (FSA). Alprostadil purchased with a valid prescription qualifies as an HSA/FSA-eligible medical expense under IRS Publication 502. [21]

Step-by-Step: Getting Alprostadil in Alaska Today

1. Schedule a telehealth intake with an Alaska-licensed MD, DO, NP, or PA specializing in men's health or urology.
2. Complete intake forms detailing your ED history, cardiovascular status, current medications, and prior PDE5 inhibitor trials.
3. Attend the video consult (15 to 30 minutes). Discuss formulation preference (injection vs. suppository) and agree on starting dose.
4. Order baseline labs at the nearest collection site if the prescriber requires them.
5. Receive your e-prescription at a retail Alaska pharmacy or a 503A compounder that ships to Alaska with cold-chain packaging.
6. Review the administration training module or video call with the clinical team for in-clinic injection demonstration via synchronous video.
7. Begin at the prescribed starting dose. Do not self-escalate without clinician guidance.
8. Follow up at 4 weeks (or sooner if you experience adverse effects) to review dose adequacy and tolerability.